Biotransplant(BTRN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN)

BTRN 35.61

-0.7%

4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: trevor john wilkinson who started this subject	7/25/2002 3:07:06 PM
From: RCMac	of 1475

BTRN's recent financing referred to in WSJ: Message 17794626 One company where Mr. Semon's firm recently invested was BioTransplant Inc., a Charlestown, Mass., biotech firm that is working on a treatment for psoriasis with partner MedImmune and on treatment for autoimmune diseases. Last month, BioTransplant received net proceeds of about $9.7 million from its offering of four million common shares at $2.50 each. The shares, which peaked above $18 in late 2000, recently traded at $1.51. BioTransplant CEO Elliot Lebowitz said people who bought shares were generally friends of the company. "I didn't have to do a road show," he said. "People came to us because they thought the stock was battered and depressed." Mr. Lebowitz agreed that venture capital is showing more interest in public biotech companies, but said the investment community's psychology remains dreary. "We're going through a period of wide-scale fear in the marketplace, and the fear is infectious," Mr. Lebowitz said.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next